The authors note the DOJ is likely to ride a wave of high-profile successes in key priority areas as well as departmental policy changes that will drive prosecutors to more aggressive criminal and civil False Claims Act enforcement related to illicit opioid distribution, pandemic fraud, and research misconduct, as well as other more typical Federal Food, Drug, and Cosmetic Act violations.
According to the authors, a demonstrated commitment to compliance, evidenced by robust and well-resourced compliance programs and supported by leaders who can serve as role models for ethical and compliant behavior, will be critical to navigating the government inquiries that are sure to come.
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find our more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.